977 results on '"Hameed, Meera"'
Search Results
102. BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology
103. Untying the Gordian knot of composite hemangioendothelioma: Discovery of novel fusions.
104. Increased Expression of Preprotachykinin-I and Neurokinin Receptors in Human Breast Cancer Cells: Implications for Bone Marrow Metastasis
105. Association of MRI T2 Signal Intensity With Desmoid Tumor Progression During Active Observation: A Retrospective Cohort Study
106. Discovery of a periosteal stem cell mediating intramembranous bone formation
107. Atypical lipomatous tumor of the hand with transformation to dedifferentiated liposarcoma: a case report
108. Fabrication and Characterization of Eco-Friendly Thin Films as Potential Optical Absorbers for Efficient Multi-Functional Opto-(Electronic) and Solar Cell Applications
109. Abstract 3556: Assessing patterns of genomic instability in recurrent osteosarcoma
110. Data from Distinct IDH1/2-associated Methylation Profile and Enrichment of TP53 and TERT Mutations Distinguish Dedifferentiated Chondrosarcoma from Conventional Chondrosarcoma
111. Supplementary Table TS1 from Distinct IDH1/2-associated Methylation Profile and Enrichment of TP53 and TERT Mutations Distinguish Dedifferentiated Chondrosarcoma from Conventional Chondrosarcoma
112. Supplementary Figure FS1 from Distinct IDH1/2-associated Methylation Profile and Enrichment of TP53 and TERT Mutations Distinguish Dedifferentiated Chondrosarcoma from Conventional Chondrosarcoma
113. Supplementary Data #1 from Genomic Profiling Identifies Association of IDH1/IDH2 Mutation with Longer Relapse-Free and Metastasis-Free Survival in High-Grade Chondrosarcoma
114. Supplementary Data from A Phase Ib/II Randomized Study of RO4929097, a Gamma-Secretase or Notch Inhibitor with or without Vismodegib, a Hedgehog Inhibitor, in Advanced Sarcoma
115. Supplementary Materials from Immunologic Correlates of the Abscopal Effect in a SMARCB1/INI1-negative Poorly Differentiated Chordoma after EZH2 Inhibition and Radiotherapy
116. Supplementary Data #3 from Genomic Profiling Identifies Association of IDH1/IDH2 Mutation with Longer Relapse-Free and Metastasis-Free Survival in High-Grade Chondrosarcoma
117. Supplementary Data from Clinical Genomic Sequencing of Pediatric and Adult Osteosarcoma Reveals Distinct Molecular Subsets with Potentially Targetable Alterations
118. Data from A Phase Ib/II Randomized Study of RO4929097, a Gamma-Secretase or Notch Inhibitor with or without Vismodegib, a Hedgehog Inhibitor, in Advanced Sarcoma
119. Figure S1 from Clinical Genomic Sequencing of Pediatric and Adult Osteosarcoma Reveals Distinct Molecular Subsets with Potentially Targetable Alterations
120. Supplementary Tables from Clinical Genomic Sequencing of Pediatric and Adult Osteosarcoma Reveals Distinct Molecular Subsets with Potentially Targetable Alterations
121. Molten Salts Approach of Poly(vinyl alcohol)-Derived Bimetallic Nickel–Iron Sheets Supported on Porous Carbon Nanosheet as an Effective and Durable Electrocatalyst for Methanol Oxidation
122. Distinct IDH1/2-associated methylation profile and enrichment of TP53 and TERT mutations distinguish dedifferentiated chondrosarcoma from conventional chondrosarcoma
123. Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial
124. Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape
125. Validation of mitotic cell quantification via microscopy and multiple whole-slide scanners
126. Dual‐mode security authentication of SrAl2O4:Eu,Dy phosphor encapsulated in electrospun cellulose acetate nanofibrous films.
127. Datasets for reporting of soft‐tissue sarcoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)
128. Current Laboratory Testing Practices for Assessment of ERBB2/HER2 in Endometrial Serous Carcinoma and Colorectal Carcinoma
129. Cathepsin protease expression in infiltrative soft tissue sarcomas: cathepsin-K correlates with infiltrative tumor growth and clinical outcomes
130. Deep Learning–Based Objective and Reproducible Osteosarcoma Chemotherapy Response Assessment and Outcome Prediction
131. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
132. Undifferentiated pleomorphic sarcoma: indolent, tail-like recurrence of a high-grade tumor
133. Elevated β-hCG associated with aggressive Osteoblastoma
134. Electrospun nanofibers for drug delivery applications: Methods and mechanism
135. Abstract A028: Growth factor signaling and kinase inhibitors regulate oncogenesis in desmoid fibromatosis by modulating activity of the beta-catenin transcription target ABL1
136. Abstract PR012: Targeted sequencing of 2,138 bone and soft tissue sarcomas reveals commonly altered pathways, subtype-independent genetic clusters, and potential therapeutic targets
137. Abstract B023: Prospective clinical genomic profiling of ewing sarcoma: ERF and FGFR1 mutations as recurrent secondary alterations of potential biological and therapeutic relevance
138. Abstract B022: Subclonal somatic copy number alterations emerge and dominate in relapsed/refractory osteosarcoma
139. Magnetic resonance imaging features and clinical course of malignant melanotic nerve sheath tumors: single institution experience over two decades
140. USP6 gene rearrangements occur preferentially in giant cell reparative granulomas of the hands and feet but not in gnathic location
141. Intracardiac Low-grade Sarcoma Following Treatment for Ewing Sarcoma
142. High Performance of Nanostructured Cu 2 O-Based Photodetectors Grown on a Ti/Mo Metallic Substrate.
143. Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas: Guideline from the College of American Pathologists in collaboration with the American Association of Neuropathologists, Association for Molecular Pathology, and Society for Neuro-Oncology
144. Symplastic/pseudoanaplastic giant cell tumor of the bone
145. The 2020 World Health Organization classification of bone tumors: what radiologists should know
146. Clinical Testing for Tumor Cell-Free DNA: College of American Pathologists Proficiency Programs Reveal Practice Trends
147. Subclonal somatic copy number alterations emerge and dominate in recurrent osteosarcoma.
148. Defining Novel DNA Virus-Tumor Associations and Genomic Correlates Using Prospective Clinical Tumor/Normal Matched Sequencing Data
149. Clinical Laboratory Testing Practices in Diffuse Gliomas Prior to Publication of 2021 World Health Organization Classification of Central Nervous System Tumors
150. Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas:Guideline from the College of American Pathologists in Collaboration with the American Association of Neuropathologists, Association for Molecular Pathology, and Society for Neuro-Oncology
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.